In contrast to findings of other blood-based studies, we found at least four NSCLC-associated markers that were involved in Ras/MAP kinase and cell growth control pathways highly relevant to cancer: DUSP6, GRB2, MDM2, and NF1 [26–30]. The gene discussed is GRB2; the disease is cancer.